Panitumumab is a fully human IgG2 monoclonal antibody that specifically binds to and inhibits the epidermal growth factor receptor (EGFR). It is widely used in both in vitro and in vivo research to study EGFR-driven cancers, including colorectal cancer, and to investigate mechanisms of targeted therapy.
Konzentration:
19.7 mg/mL
Molekulargewicht:
147 kDa
Reinheit:
99.40% (May vary between batches)
CAS Nummer:
[339177-26-3]
Target-Kategorie:
EGFR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten